Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Sirona Biochem Corp
V.SBM
Alternate Symbol(s):
SRBCF
Healthcare
Biotechnology
Sirona Biochem Corp. is a cosmetic ingredient and drug discovery company with a proprietary technology platform developed at its laboratory facility in France with a specialization in the stabilization of carbohydrate molecules. The Company is exploring the areas of diabetes, dyschromia, anti-aging, anti-cellulite and antiviral therapies and relies on a business model of licensing patents to...
large organizations in return for up-front and milestone payments as well as royalties. Its two most advanced programs are the cosmetic skin lightener and diabetes drug. The Company's TFC-1067 is for the treatment of Dyschromia (Dark spots on the skin). GlycoProteMim is a novel anti-aging compound. GlycoProteMim is based on the naturally occurring glycoproteins found in Antarctic fish, known to protect them against environmental stressors. It is focused on three current antiviral categories: Neuraminidase Inhibitors, Nucleoside Analogs and Iminosugars. Its wholly owned subsidiary is TFChem S.A.R.L.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:SBM)
New Post
View:
Posts & Comments
Threaded Posts
Prev
...
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
...
Next
(4)
•••
bazooka73
X
View Profile
View Bullboard History
Comment by
bazooka73
on Jun 21, 2022 11:20am
RE:RE:RE:RE:RE:RE:RE:RE:new tweet from SBM
CEO Quarterly Update 2021
(1064)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jun 21, 2022 11:00am
RE:RE:RE:RE:RE:RE:RE:new tweet from SBM
What is the date on your document? Mine was written on December 13, 2021 and it seems to say the Wanbang work was being ceased because of the drug going generic. "however, given the generic
...more
Discover Options Trading Strategies to Minimize your Tax Burden
posted Dec 01, 2024 9:00am by
Bank of Montreal
-
|
Options trading doesn’t come without tax implications, but there are ways investors can still optimize their after-tax returns with just a little bit of understanding. Approaches for investors to keep in mind are holding periods, wash-sales rule, tax advantaged accounts, and qualified cover calls. BMO’s enhanced InvestorLine platform. Industry-leading tools and capabilities specifically designed to empower options traders. ...read more
(4)
•••
bazooka73
X
View Profile
View Bullboard History
Comment by
bazooka73
on Jun 21, 2022 2:24am
RE:RE:RE:RE:RE:RE:new tweet from SBM
Did you read this? "We are pleased to inform our shareholders that Sirona and Wanbang have signed a binding Letter of Intent (LOI) to collaborate on licencing efforts for Sirona’s SGLT2
...more
(1064)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jun 21, 2022 2:01am
RE:RE:RE:RE:RE:new tweet from SBM
Did you read this or did you not read this: This year, Empagliflozin (developed by Boehringer Ingelheim and Eli Lilly) failed to uphold patent protection in China, which created a generic environment
...more
(4)
•••
bazooka73
X
View Profile
View Bullboard History
Comment by
bazooka73
on Jun 21, 2022 12:23am
RE:RE:RE:RE:new tweet from SBM
but they are for TFC-039
(10)
•••
PeterG
X
View Profile
View Bullboard History
Comment by
PeterG
on Jun 21, 2022 12:10am
RE:RE:RE:new tweet from SBM
Wangbang is not the manufacturer of 1067.
(1978)
•••
lscfa
X
View Profile
View Bullboard History
Comment by
lscfa
on Jun 20, 2022 11:58pm
RE:RE:new tweet from SBM
I'm surprized Sirona is keeping Wanbang to manufacture 1067. Maybe, it's temporary until they find another contract manufacturer.
(72)
•••
MirrorWorldMan
X
View Profile
View Bullboard History
Comment by
MirrorWorldMan
on Jun 20, 2022 9:32pm
RE:RE:How many advisor options issued?
I stand corrected. Wolfgang just joined the Advisory Board and is not on the BoD or even an employee. This is minimal impact, as advisory board members are given an honorarium for their answers to
...more
(1064)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jun 20, 2022 8:03pm
RE:RE:RE:new tweet from SBM
There is dialogue there. Not sure I can classify any of it as answers as to how, when and where - but it does talk about it.
(101)
•••
biorun
X
View Profile
View Bullboard History
Comment by
biorun
on Jun 20, 2022 6:39pm
RE:RE:new tweet from SBM
If you look at the most recent presentation updated last week, there may be some answers there. I suspect most didn't bother but it is worth a read.
(1064)
•••
Pandora
X
View Profile
View Bullboard History
Comment by
Pandora
on Jun 20, 2022 6:20pm
RE:new tweet from SBM
Back in December it was announced that the program in China with Wanbang was being dropped because Boehringer had announced a patent issue and the SGLT2 drug was going to be issued as a generic. Or
...more
(12)
•••
LakeOromocto
X
View Profile
View Bullboard History
Post by
LakeOromocto
on Jun 20, 2022 4:54pm
New video SBM
https://youtu.be/P0wbOfXi99I
(13)
•••
doonery
X
View Profile
View Bullboard History
Comment by
doonery
on Jun 20, 2022 12:19pm
RE:RE:RE:RE:RE:Senior VP from Bayer as Board Member
i agree biorun,,,as usual i think you are correct,,in fact I@ bought some more at .31,,,I think 40+,by thurs/fri.GLTA,,,
(13)
•••
doonery
X
View Profile
View Bullboard History
Comment by
doonery
on Jun 20, 2022 12:18pm
RE:RE:RE:RE:RE:Senior VP from Bayer as Board Member
i agree biorun,,,as usual i think you are correct,,in fact I bought some more at .31,,,I think 40+,by thurs/fri.GLTA,,,
Prev
...
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >